Article
Unveiling the molecular features, relevant immune and clinical characteristics of SIGLEC15 in thyroid cancer
9 Sept 2022
Abstract excerpt
The groundbreaking research work about SIGLEC15 has raised it as a potential promising target in cancer immunotherapy. Unfortunately, the role of SIGLEC15 in thyroid carcinoma (THCA) remains obscure. Public and home multi-omics data were collected to investigate the role of SIGLEC15 in THCA in our study. SIGLEC15 was upregulated in THCA tumor tissue compared to nontumor tissue in both mRNA and protein levels;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
